⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Epia Neuro and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Epia Neuro
↗Alameda, California, USA
Epia Neuro is a San Francisco-based neurotechnology startup focused on developing intent-driven brain-computer interface (BCI) systems. The company aims to restore independence for individuals with neurological conditions, starting with stroke-related motor impairment and expanding into cognitive decline and other disorders.
The company's platform features a minimally invasive, long-lifetime 'read/write' BCI device that is implanted in the skull without penetrating the dura. This system integrates with AI-driven algorithms and assistive devices (such as a motorized glove) to translate neural intent into functional movement in real time. The technology is designed for accessibility, with a surgical procedure lasting less than an hour and a non-invasive, headset-based charging system.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:Brain-Computer Interface (BCI) / Neurotechnology
SIZE & FINANCIALS
Employees:11-50
Founded:2026
Ownership:private
Status:operating
FUNDING
Stage:Early Stage
PIPELINE
Stage:Preclinical
Lead Drug Stage:First-in-human system demonstrations planned for 2026
Modalities:Brain-Computer Interface, Neuromodulation, AI/Machine Learning
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Lenox Hill Hospital (Department of Neurosurgery) - planned first-in-human system demonstrations
COMPETITION
Position:Emerging
Competitors:Neuralink, Paradromics, INBRAIN Neuroelectronics, Neuracle Technology
LEADERSHIP
Key Executives:
Michel Maharbiz - CEO
Gil Mandelbaum - Chief Technology and Science Officer
Michelle Patruno - COO
LINKS
Website:epianeuro.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Epia Neuro. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.